Hims vs SnagRx: Which GLP-1 Provider Is Better?
Short answer: Hims scores higher on our rubric, 7.9/10 against 3.9/10. Full reasoning, pricing and the cases where the other one wins are below.
Hims beats SnagRx overall, scoring 7.9/10 vs 3.9/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; SnagRx is published $69/mo; total not verified. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose SnagRx for people comparing the lowest published compounded-semaglutide medication floor who will verify the consultation fee and complete total before paying a brand-new storefront with no independent review record.
A side-by-side look at Hims and SnagRx to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hims
#7 of 54The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, and Zepbound paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.
Visit HimsSnagRx
#53 of 54SnagRx is a cash-pay compounded GLP-1 storefront operated by Modern Metabolic Medicine, Inc., the same company behind Embody and RodeoMeds. It advertises compounded semaglutide at $69/mo against a $299 regular price and compounded tirzepatide at $119 against $399, but its terms refer to non-refundable medical consult fees, so those are medication floors rather than verified all-in totals. Shipping is free at a stated 1-2 days. Prescriptions are filled through named partner pharmacies including RedRock Pharmacy. The site launched in January 2026 and its Trustpilot profile, though claimed, still carries no reviews.
Visit SnagRx| Feature | Hims | SnagRx |
|---|---|---|
| Our Score | 7.9/10 | 3.9/10 |
| Headline Price | $188 first month, then $298/mo | published $69/mo; total not verified |
| Medication Type | Brand | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors | People comparing the lowest published compounded-semaglutide medication floor who will verify the consultation fee and complete total before paying a brand-new storefront with no independent review record |
| Watch out for | Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable. | No independent review record at all. The Trustpilot profile is claimed and shows zero reviews, so the '125k+ Happy Customers' homepage claim cannot be verified anywhere |
| Ranking | #7 | #53 |
| Get started | Visit Hims | Visit SnagRx |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Do not confuse its $69 price with the current brand-name GLP-1 menu.
- −The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
- −Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
SnagRx
Pros
- +The lowest advertised compounded-semaglutide medication floor on this site at $69/mo, if the promotional rate holds; the consultation fee and all-in total remain unresolved
- +Names its partner pharmacy publicly with a link (RedRock Pharmacy), which most competitors do not do
- +Free 1-2 day shipping with a stated one-day turnaround from intake to a written prescription
- +The site markets a locked medication rate with no monthly membership and publishes a separate refund policy; its terms still leave a possible medical consult fee unresolved
- +States service in all 50 states plus Washington D.C.
Cons
- −No independent review record at all. The Trustpilot profile is claimed and shows zero reviews, so the '125k+ Happy Customers' homepage claim cannot be verified anywhere
- −The $69 price sits under a countdown timer that is a standing feature of the page rather than a dated deadline, next to a 'locked-in for life' claim. The regular price is $299
- −'Cancel Anytime' appears three times on the homepage, but the terms say cancellation deadlines 'will be disclosed at checkout or in your account'. A deadline you only see after committing is not cancel-anytime
- −'No Hidden Fees' is contradicted by the terms, which refer to medical consult fees that are not refundable
- −All sales are final once medication is dispensed; refunds are limited to medication not yet shipped where a provider finds you ineligible
- −No named clinicians, no medical director, no published lab or video-visit detail
- −Shares its operating entity with Embody and RodeoMeds. Neither SnagRx nor Embody discloses the relationship on its own site, so a shopper comparing them would not know they are one company
- −Cash-pay only, no insurance billing and no prior-authorisation help
Our Verdict
Hims edges out SnagRx with a score of 7.9/10 vs 3.9/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; SnagRx is published $69/mo; total not verified.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hims and SnagRx.
- Hims vs Fridays$249/mo month-to-month
- Hims vs Eden Health GLP-1from $249/mo
- Hims vs Hone Healthfrom $309/mo
- SnagRx vs Calibratepublished $199/mo; total not verified
- SnagRx vs FeelGoodfrom $149/mo
- SnagRx vs GoodRx Care$119/mo subscription + medication
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Hims · 7.9/10